Equibles does not estimate personal net worth.
Get an email with a short summary when Bio-Rad Laboratories, Inc. publishes a filing, an earnings call transcript or a press release.
Get BIO alertsNorman Schwartz is recorded as CFO at Bio-Rad Laboratories, Inc. (BIO) since February 9, 2024, Board Member at Bio-Rad Laboratories, Inc. (BIO) since January 1, 1995 and CEO at Bio-Rad Laboratories, Inc. (BIO). The newest filing on record that lists Norman Schwartz as CEO and Board Member at Bio-Rad Laboratories, Inc. (BIO) is dated March 25, 2026. Bio-Rad Laboratories, Inc. reported in an 8-K filed February 14, 2024 that Norman Schwartz was appointed principal financial officer, effective February 9, 2024. The proxy statement of Bio-Rad Laboratories, Inc. reports total compensation of $7,995,841 for Norman Schwartz in fiscal 2025, including a base salary of $1,089,877. Disclosed compensation is on record for 9 fiscal years. Norman Schwartz has spoken on 24 earnings calls across 1 company, most recently for Bio-Rad Laboratories, Inc. on August 4, 2026. Bio-Rad Laboratories, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Bio-Rad Laboratories, Inc. includes Roop K. Lakkaraju (CFO and Chief Accounting Officer), Roop Lakkaraju (CFO), Jonathan DiVincenzo (COO) and 7 others.
“On February 9, 2024, the Company’s board of directors appointed Norman Schwartz, the Company’s President and Chief Executive Officer and the Chairman of the Board, as the Company’s principal financial officer until a permanent replacement for Mr. Daskal has been appointed.”
“So you know John and Rue have covered the quarters mechanics well so I wanted to spend some time on the key areas of focus for us. First, I wanted to talk about how our team is approaching the evolution of our business.”
“You know, as you've heard from John and Rue, you know, we are operating in a challenged and challenging environment.”
“So, I just thought I'd take a few minutes to close today's call with a few thoughts. Maybe to start out, you know, I think as we enter 2026, you know, we are seeing early signs of stabilization across several of our core markets with NIH and related funding set and study improvements in biopharma funding.”
“You know, I think as we all know, the second quarter remained tumultuous, but it does seem we're all getting used to it uh for what it's worth uh you know i think uh you know in any case it's good to see our customers adapting to the current situation and figuring out how to navigate uh and you know it's nice to see…”
“However, we are still in the golden age of biology, and I continue to see a long runway ahead for life science research and for diagnostics, the two principal markets that we serve.”
2024-02-09–present
1995-01-01–present
Last confirmed March 25, 2026
Start not stated–present
Last confirmed March 25, 2026
Medical Devices · Healthcare
CEO, CFO, Board Member
1995-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Bio-Rad Laboratories, Inc. (BIO) | Chief Executive Officer and Chairman | $1,089,877 | $7,995,841 |
| 2024 | Bio-Rad Laboratories, Inc. (BIO) | Chief Executive Officer and Chairman | $1,059,500 | $8,289,471 |
| 2023 | Bio-Rad Laboratories, Inc. (BIO) | President, Chief Executive Officer and Chairman | $1,040,000 | $7,463,878 |
| 2022 | Bio-Rad Laboratories, Inc. (BIO) | President, Chief Executive Officer and Chairman | $1,030,154 | $7,527,985 |
| 2021 | Bio-Rad Laboratories, Inc. (BIO) | President, Chief Executive Officer and Chairman | $987,885 | $8,695,925 |
| 2020 | Bio-Rad Laboratories, Inc. (BIO) | President, Chief Executive Officer and Chairman | $986,538 | $7,992,423 |
| 2019 | Bio-Rad Laboratories, Inc. (BIO) | President, Chief Executive Officer and Chairman | $950,000 | $7,261,053 |
| 2018 | Bio-Rad Laboratories, Inc. (BIO) | President, Chief Executive Officer and Chairman | $942,468 | $7,639,414 |
| 2017 | Bio-Rad Laboratories, Inc. (BIO) | President, Chief Executive Officer and Chairman | $922,022 | $5,404,676 |
